Publicacions en què col·labora amb LUIS CARREÑO PÉREZ (61)

2017

  1. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2016

  1. Multiobserver reliability of ultrasound assessment of salivary glands in patients with established primary sjögren syndrome

    Journal of Rheumatology, Vol. 43, Núm. 10, pp. 1858-1863

  2. Structural damage in rheumatoid arthritis: Comparison between tendon damage evaluated by ultrasound and radiographic damage

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1042-1046

  3. The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 609-617

2015

  1. Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

    Clinical Rheumatology, Vol. 34, Núm. 5, pp. 935-942

  2. Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis

    Rheumatology International, Vol. 35, Núm. 6, pp. 1021-1025

  3. Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 8, pp. 1408-1414

2014

  1. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?

    Rheumatology (United Kingdom), Vol. 53, Núm. 11, pp. 2088-2094

  2. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: Results from a nationwide cohort in Spain (LESIMAB)

    Lupus, Vol. 23, Núm. 10, pp. 1014-1022

2013

  1. Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-α)

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 776-778

  2. Patient self-assessment and physician's assessment of rheumatoid arthritis activity: Which is more realistic in remission status? A comparison with ultrasonography

    Rheumatology (United Kingdom), Vol. 52, Núm. 12, pp. 2243-2250

  3. Pruebas serológicas en enfermedades autoinmunes

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 34, pp. 2084-2092

  4. Pruebas serológicas en enfermedades autoinmunes

    Medicine (Spain), Vol. 11, Núm. 34, pp. 2084-2092

  5. Ultrasound Joint Inflammation in Rheumatoid Arthritis in Clinical Remission: How Many and Which Joints Should Be Assessed?

    Arthritis Care and Research, Vol. 65, Núm. 4, pp. 512-517

2012

  1. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: The LESIMAB study

    Lupus, Vol. 21, Núm. 10, pp. 1063-1076

2010

  1. Interleucinas en la fisiopatología de la artritis reumatoide: más allá de las citocinas proinflamatorias

    Reumatologia Clinica, Vol. 6, Núm. SUPPL. 3

2009

  1. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 61, Núm. 4, pp. 419-424

  2. Cognitive dysfunction in systemic lupus erythematosus: Prevalence and correlates

    European Neurology, Vol. 62, Núm. 1, pp. 49-55

  3. Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583

  4. Pericardial tamponade in a patient with polymyalgia rheumatica

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 1 SUPPL. 52